Memorial Sloan Kettering medical oncologist Clifford A. Hudis has been elected President of the American Society of Clinical Oncology (ASCO), the world’s leading professional organization representing more than 30,000 physicians who care for people with cancer. As ASCO’s President, Dr. Hudis will work with its membership to further the society’s goals of improving all aspects of cancer care, including access, effectiveness, and affordability. He will be introduced as President-Elect during ASCO’s 48th annual meeting in June 2012 and will serve a one-year term beginning in June 2013.
Dr. Hudis, Chief of the Breast Cancer Medicine Service, is a national leader in practice-changing translational research and clinical care. He has an active medical practice devoted solely to the treatment of patients with breast cancer, and he has a particular interest in applying emerging technology to both clinical and research settings. Dr. Hudis’s research is focused on prevention of the disease, prevention of recurrence after surgery, and treatment of recurrences.
“We are delighted and proud that Cliff Hudis has been elected President of ASCO,” says Memorial Sloan Kettering President Craig B. Thompson. “Cliff has made MSKCC his professional home since joining the institution as a fellow in 1988. He is an outstanding breast cancer clinician, researcher, and teacher. His investigative acumen has improved the care of patients with all stages of the disease, placing him among the most influential physician-scientists in the field. ASCO is indeed fortunate to have him.”